hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_05947.1
Confidence: Very High  
ProteinsGenename | Protein Name | Uniprot Annotation Score | Links |
---|---|---|---|
E2F5 | Transcription factor E2F5 (E2F-5) | 5 | UniProt   NCBI |
RBL2 | Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2) | 5 | UniProt   NCBI |
TFDP2 | Transcription factor Dp-2 (E2F dimerization partner 2) | 5 | UniProt   NCBI |
E2F1 | Transcription factor E2F1 (E2F-1) (PBR3) (Retinoblastoma-associated protein 1) (RBAP-1) (Retinoblastoma-binding protein 3) (RBBP-3) (pRB-binding protein E2F-1) | 5 | UniProt   NCBI |
E2F2 | Transcription factor E2F2 (E2F-2) | 5 | UniProt   NCBI |
MCIDAS | Multicilin (Multiciliate differentiation and DNA synthesis-associated cell cycle protein) (McIdas protein) (Protein Idas) | 5 | UniProt   NCBI |
RBL1 | Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1) | 5 | UniProt   NCBI |
E2F3 | Transcription factor E2F3 (E2F-3) | 5 | UniProt   NCBI |
Enrichments
Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
---|---|---|---|---|
  REAC:R-HSA-69236 | 3.22101990612e-15 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | G1 Phase |
  REAC:R-HSA-69231 | 3.22101990612e-15 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | Cyclin D associated events in G1 |
  WP:WP179 | 1.19822903986e-12 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | Cell cycle |
  KEGG:04110 | 4.29104596965e-12 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | Cell cycle |
  REAC:R-HSA-1362300 | 6.43259852157e-12 | 0.625 | E2F5 RBL1 E2F1 RBL2 TFDP2 | Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 |
  REAC:R-HSA-453279 | 1.52268974335e-11 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | Mitotic G1 phase and G1/S transition |
  REAC:R-HSA-1362277 | 1.83437227329e-11 | 0.625 | E2F5 RBL1 E2F1 RBL2 TFDP2 | Transcription of E2F targets under negative control by DREAM complex |
  REAC:R-HSA-1538133 | 1.40639331372e-10 | 0.625 | E2F5 RBL1 E2F1 RBL2 TFDP2 | G0 and Early G1 |
  REAC:R-HSA-69205 | 1.72573247338e-10 | 0.625 | E2F5 RBL1 E2F1 RBL2 TFDP2 | G1/S-Specific Transcription |
  KEGG:04218 | 9.46714786169e-10 | 0.75 | E2F1 RBL1 E2F2 E2F3 E2F5 RBL2 | Cellular senescence |
  REAC:R-HSA-9659787 | 1.86009193219e-08 | 0.5 | TFDP2 E2F3 E2F2 E2F1 | Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects |
  REAC:R-HSA-9661069 | 1.86009193219e-08 | 0.5 | TFDP2 E2F3 E2F2 E2F1 | Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) |
  REAC:R-HSA-69278 | 1.24107692715e-07 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | Cell Cycle, Mitotic |
  REAC:R-HSA-2559585 | 3.18690821415e-07 | 0.5 | TFDP2 E2F3 E2F2 E2F1 | Oncogene Induced Senescence |
  REAC:R-HSA-9687139 | 4.07608325548e-07 | 0.5 | TFDP2 E2F3 E2F2 E2F1 | Aberrant regulation of mitotic cell cycle due to RB1 defects |
  REAC:R-HSA-9675126 | 5.13916796434e-07 | 0.5 | TFDP2 E2F3 E2F2 E2F1 | Diseases of mitotic cell cycle |
  REAC:R-HSA-1640170 | 5.28730863704e-07 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | Cell Cycle |
  REAC:R-HSA-69206 | 6.01158968587e-07 | 0.625 | E2F5 RBL1 E2F1 RBL2 TFDP2 | G1/S Transition |
  WP:WP5180 | 1.05136071493e-06 | 0.5 | E2F5 RBL1 RBL2 TFDP2 | DYRK1A involvement regarding cell proliferation in brain development |
  REAC:R-HSA-6791312 | 1.15734333971e-06 | 0.5 | TFDP2 RBL1 RBL2 E2F1 | TP53 Regulates Transcription of Cell Cycle Genes |
  GO:0005667 | 1.99498512604e-06 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | transcription regulator complex |
  WP:WP45 | 2.107642217e-06 | 0.5 | TFDP2 E2F3 E2F2 E2F1 | G1 to S cell cycle control |
  WP:WP2446 | 7.01018894981e-06 | 0.5 | TFDP2 E2F3 E2F2 E2F1 | Retinoblastoma gene in cancer |
  REAC:R-HSA-69202 | 1.34761418673e-05 | 0.5 | E2F5 E2F1 RBL2 TFDP2 | Cyclin E associated events during G1/S transition |
  REAC:R-HSA-69656 | 1.48598663575e-05 | 0.5 | E2F5 E2F1 RBL2 TFDP2 | Cyclin A:Cdk2-associated events at S phase entry |
  REAC:R-HSA-6804114 | 1.55196545534e-05 | 0.375 | TFDP2 RBL2 RBL1 | TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest |
  KEGG:05219 | 3.77309774533e-05 | 0.375 | E2F1 E2F2 E2F3 | Bladder cancer |
  REAC:R-HSA-2559580 | 3.95433493773e-05 | 0.5 | TFDP2 E2F3 E2F2 E2F1 | Oxidative Stress Induced Senescence |
  CORUM:5144 | 7.17483486175e-05 | 0.25 | E2F1 RBL1 | E2F1-p107-cyclinA complex |
  CORUM:1473 | 7.17483486175e-05 | 0.25 | E2F5 RBL2 | E2F5-RB2-DP1 complex |
  REAC:R-HSA-2173796 | 0.000162162924374 | 0.375 | E2F5 RBL1 TFDP2 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
  REAC:R-HSA-69242 | 0.000194205912298 | 0.5 | E2F5 E2F1 RBL2 TFDP2 | S Phase |
  KEGG:05218 | 0.000198526350575 | 0.375 | E2F1 E2F2 E2F3 | Melanoma |
  CORUM:1471 | 0.000239030245992 | 0.25 | E2F5 RBL2 | pRb2/p130-multimolecular complex (RB2, E2F5, HDAC1, SUV39H1, P300) |
  CORUM:2975 | 0.000239030245992 | 0.25 | E2F5 RBL1 | SMAD3-E2F4/5-p107-DP1 complex |
  CORUM:5117 | 0.000239030245992 | 0.25 | E2F5 RBL2 | RBL2 complex (DNMT1, E2F4, E2F5, HDAC1, SUV39H1, RBL2) |
  KEGG:05214 | 0.000262665274355 | 0.375 | E2F1 E2F2 E2F3 | Glioma |
  KEGG:05223 | 0.000262665274355 | 0.375 | E2F1 E2F2 E2F3 | Non-small cell lung cancer |
  REAC:R-HSA-2559583 | 0.00028497836115 | 0.5 | TFDP2 E2F3 E2F2 E2F1 | Cellular Senescence |
  KEGG:05212 | 0.000312260387677 | 0.375 | E2F1 E2F2 E2F3 | Pancreatic cancer |
  WP:WP4685 | 0.000331238553774 | 0.375 | E2F1 E2F2 E2F3 | Melanoma |
  KEGG:05220 | 0.000339227897214 | 0.375 | E2F1 E2F2 E2F3 | Chronic myeloid leukemia |
  CORUM:1474 | 0.000358447219737 | 0.25 | E2F5 RBL1 | SMAD3/4-E2F4/5-p107-DP1 complex |
  CORUM:5118 | 0.000358447219737 | 0.25 | E2F5 RBL2 | RBL2 complex (E2F4, E2F5, HDAC1, SUV39H1, P300, RBL2) |
  CORUM:6444 | 0.000358447219737 | 0.25 | RBL2 RBL1 | SMAR1-HDAC1-SIN3A-SIN3B-p107-p130 repressor complex |
  REAC:R-HSA-2173793 | 0.000443554013344 | 0.375 | E2F5 RBL1 TFDP2 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
  KEGG:01522 | 0.000462486513354 | 0.375 | E2F1 E2F2 E2F3 | Endocrine resistance |
  WP:WP4255 | 0.00046287066695 | 0.375 | E2F1 E2F2 E2F3 | Non small cell lung cancer |
  KEGG:05222 | 0.000533899657075 | 0.375 | E2F1 E2F2 E2F3 | Small cell lung cancer |
  REAC:R-HSA-111448 | 0.000557398190654 | 0.25 | TFDP2 E2F1 | Activation of NOXA and translocation to mitochondria |
  REAC:R-HSA-68911 | 0.000557398190654 | 0.25 | E2F1 E2F3 | G2 Phase |
  KEGG:05215 | 0.000612252918956 | 0.375 | E2F1 E2F2 E2F3 | Prostate cancer |
  WP:WP4263 | 0.000821419342632 | 0.375 | E2F1 E2F2 E2F3 | Pancreatic adenocarcinoma pathway |
  WP:WP4658 | 0.00109108919451 | 0.375 | E2F1 E2F2 E2F3 | Small cell lung cancer |
  GO:0000977 | 0.00123422340003 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
  GO:0090575 | 0.00139940799074 | 0.625 | E2F5 E2F3 E2F1 E2F2 TFDP2 | RNA polymerase II transcription regulator complex |
  WP:WP53 | 0.00157457895347 | 0.25 | RBL2 RBL1 | ID signaling pathway |
  REAC:R-HSA-1912408 | 0.00158030541683 | 0.375 | TFDP2 E2F3 E2F1 | Pre-NOTCH Transcription and Translation |
  KEGG:04934 | 0.00164110254365 | 0.375 | E2F1 E2F2 E2F3 | Cushing syndrome |
  KEGG:05224 | 0.00172091419679 | 0.375 | E2F1 E2F2 E2F3 | Breast cancer |
  KEGG:05160 | 0.00188812744317 | 0.375 | E2F1 E2F2 E2F3 | Hepatitis C |
  KEGG:05226 | 0.00188812744317 | 0.375 | E2F1 E2F2 E2F3 | Gastric cancer |
  WP:WP236 | 0.00189816362482 | 0.375 | E2F1 RBL2 RBL1 | Adipogenesis |
  REAC:R-HSA-139915 | 0.00200443712543 | 0.25 | TFDP2 E2F1 | Activation of PUMA and translocation to mitochondria |
  GO:0000785 | 0.00212566298582 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | chromatin |
  GO:0000976 | 0.0022345160433 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | transcription cis-regulatory region binding |
  GO:0001067 | 0.0022504485569 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | transcription regulatory region nucleic acid binding |
  REAC:R-HSA-170834 | 0.00237597190289 | 0.375 | E2F5 RBL1 TFDP2 | Signaling by TGF-beta Receptor Complex |
  WP:WP366 | 0.00261051604069 | 0.375 | E2F5 RBL2 RBL1 | TGF beta signaling pathway |
  KEGG:05161 | 0.00271802931306 | 0.375 | E2F1 E2F2 E2F3 | Hepatitis B |
  KEGG:05206 | 0.00271802931306 | 0.375 | E2F1 E2F2 E2F3 | MicroRNAs in cancer |
  REAC:R-HSA-1912422 | 0.00281136504087 | 0.375 | TFDP2 E2F3 E2F1 | Pre-NOTCH Expression and Processing |
  GO:1990837 | 0.00309645370336 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | sequence-specific double-stranded DNA binding |
  GO:0032993 | 0.00320293753229 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | protein-DNA complex |
  KEGG:05225 | 0.00336544876328 | 0.375 | E2F1 E2F2 E2F3 | Hepatocellular carcinoma |
  GO:0001216 | 0.00363013100998 | 0.625 | E2F5 E2F3 E2F1 E2F2 TFDP2 | DNA-binding transcription activator activity |
  WP:WP4262 | 0.00364116708552 | 0.375 | E2F1 E2F2 E2F3 | Breast cancer pathway |
  REAC:R-HSA-3700989 | 0.00388943076684 | 0.5 | TFDP2 RBL1 RBL2 E2F1 | Transcriptional Regulation by TP53 |
  KEGG:05167 | 0.00396473051169 | 0.375 | E2F1 E2F2 E2F3 | Kaposi sarcoma-associated herpesvirus infection |
  CORUM:5614 | 0.00407177869695 | 0.25 | RBL2 RBL1 | Emerin complex 32 |
  REAC:R-HSA-113501 | 0.00433819320746 | 0.25 | TFDP2 E2F1 | Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
  REAC:R-HSA-9006936 | 0.00455165033631 | 0.375 | E2F5 RBL1 TFDP2 | Signaling by TGFB family members |
  KEGG:05169 | 0.00486719923682 | 0.375 | E2F1 E2F2 E2F3 | Epstein-Barr virus infection |
  GO:0043565 | 0.00508872640915 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | sequence-specific DNA binding |
  GO:0003690 | 0.00518576601331 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | double-stranded DNA binding |
  KEGG:05163 | 0.00589487948597 | 0.375 | E2F1 E2F2 E2F3 | Human cytomegalovirus infection |
  KEGG:05166 | 0.00645803759106 | 0.375 | E2F1 E2F2 E2F3 | Human T-cell leukemia virus 1 infection |
  REAC:R-HSA-113510 | 0.0128161014463 | 0.25 | TFDP2 E2F1 | E2F mediated regulation of DNA replication |
  REAC:R-HSA-212436 | 0.0167421784996 | 0.625 | E2F5 RBL1 E2F1 RBL2 TFDP2 | Generic Transcription Pathway |
  KEGG:05165 | 0.0207258251199 | 0.375 | E2F1 RBL2 RBL1 | Human papillomavirus infection |
  REAC:R-HSA-114452 | 0.0240813966337 | 0.25 | TFDP2 E2F1 | Activation of BH3-only proteins |
  GO:0005694 | 0.0263739534621 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | chromosome |
  REAC:R-HSA-73857 | 0.0284039231402 | 0.625 | E2F5 RBL1 E2F1 RBL2 TFDP2 | RNA Polymerase II Transcription |
  REAC:R-HSA-157118 | 0.0303228740897 | 0.375 | TFDP2 E2F3 E2F1 | Signaling by NOTCH |
  REAC:R-HSA-8953750 | 0.0310226901604 | 0.25 | TFDP2 E2F1 | Transcriptional Regulation by E2F6 |
  GO:0003677 | 0.0433468686155 | 0.875 | E2F1 RBL1 TFDP2 E2F2 E2F3 E2F5 RBL2 | DNA binding |
  KEGG:04350 | 0.0474398326563 | 0.25 | E2F5 RBL1 | TGF-beta signaling pathway |
Edges
Protein 1 | Protein 2 | Score | ProteomeHD | Evidence |
---|---|---|---|---|
 E2F5 |  TFDP2 | 0.998 |            | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     boldt_WMM     |
 TFDP2 |  E2F2 | 0.997 |            | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     |
 RBL2 |  RBL1 | 0.996 | 0.118           | bioplex_WMM     bioplex3_WMM     WMM_only     boldt_WMM     |
 TFDP2 |  E2F3 | 0.996 | 0.152           | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     |
 TFDP2 |  E2F1 | 0.991 |            | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     |
 MCIDAS |  TFDP2 | 0.985 |            | bioplex3_WMM     bioplex3_HCT116     boldt_WMM     WMM_only     |
 RBL2 |  TFDP2 | 0.967 | 0.122           | bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 RBL1 |  TFDP2 | 0.966 | 0.158           | bioplex3_WMM     bioplex3_HCT116     WMM_only     |
 E2F2 |  E2F3 | 0.961 |            | bioplex_WMM     bioplex3_WMM     WMM_only     |
 E2F5 |  E2F2 | 0.959 |            | bioplex_WMM     bioplex3_WMM     WMM_only     |
 E2F5 |  E2F3 | 0.924 |            | bioplex_WMM     bioplex3_WMM     WMM_only     |
 MCIDAS |  E2F2 | 0.902 |            | bioplex3_WMM     WMM_only     |
 MCIDAS |  E2F3 | 0.902 |            | bioplex3_WMM     WMM_only     |
 MCIDAS |  E2F5 | 0.892 |            | bioplex_WMM     bioplex3_WMM     WMM_only     boldt_WMM     |
 RBL1 |  E2F2 | 0.703 |            | bioplex3_WMM     WMM_only     |
 RBL2 |  E2F2 | 0.676 |            | bioplex3_WMM     WMM_only     |
 E2F1 |  E2F3 | 0.582 |            | bioplex_WMM     bioplex3_WMM     WMM_only     |
 E2F1 |  E2F2 | 0.568 |            | bioplex_WMM     bioplex3_WMM     WMM_only     |
 E2F5 |  E2F1 | 0.541 |            | bioplex_WMM     bioplex3_WMM     WMM_only     |
 RBL1 |  E2F3 | 0.468 | 0.138           | bioplex3_WMM     WMM_only     |
 RBL1 |  MCIDAS | 0.455 |            | bioplex3_WMM     WMM_only     |
 RBL2 |  E2F3 | 0.418 | 0.12           | bioplex3_WMM     WMM_only     |
 RBL2 |  MCIDAS | 0.405 |            | bioplex3_WMM     WMM_only     |
 RBL2 |  E2F5 | 0.404 |            | bioplex3_WMM     WMM_only     |
 RBL1 |  E2F5 | 0.384 |            | bioplex3_WMM     WMM_only     |
 MCIDAS |  E2F1 | 0.214 |            | bioplex3_WMM     WMM_only     |
 RBL1 |  E2F1 | 0.146 |            | bioplex3_WMM     WMM_only     |
 RBL2 |  E2F1 | 0.131 |            | bioplex3_WMM     WMM_only     |
Related Complexes